BALLARD MANN: Open Payments
NPI 1942580048 · BAKER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 26 payments from 14 companies in 2025. Trend: 2023 $713 · 2024 $408 · 2025 $494
Food & beverage: $494
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $95 |
| ABBVIE INC. | 3 | $58 |
| Novo Nordisk Inc | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| PFIZER INC. | 2 | $44 |
| SANOFI PASTEUR INC. | 2 | $36 |
| Abbott Laboratories | 1 | $32 |
| Organon LLC | 1 | $24 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
Products named: QULIPTA, MOUNJARO, Kerendia, JARDIANCE, BEYFORTUS, FREESTYLE LIBRE 3, PREVNAR 20, ZORYVE.
Industry payments across LA — which companies pay providers there.
